Influence of Inflammatory and Oxidative Stress Pathways on Longitudinal Symptom Experiences in Children With Leukemia

Marilyn J. Hockenberry, Wei Pan, Michael E. Scheurer, Mary C. Hooke, Olga Taylor, Kari Koerner, David W Montgomery, Susan Whitman, Pauline Mitby, Ida M Moore

Research output: Contribution to journalArticle

Abstract

Purpose: The purpose of this study was to explore the influence of oxidative stress (F2-isoprostanes) and inflammatory (interleukin [IL]-8) biomarkers on symptom trajectories during the first 18 months of childhood leukemia treatment. Method: A repeated-measures design was used to evaluate symptoms experienced by 218 children during treatment. A symptom cluster (fatigue, pain, and nausea) was explored over four time periods: initiation of post-induction therapy, 4 and 8 months into post-induction therapy, and the beginning of maintenance therapy (12 months postinduction). F2-isoprostanes and IL-8 were evaluated in cerebrospinal fluid (CSF) samples collected at baseline (diagnosis) and then at the four time periods. The longitudinal relationships of these biomarkers with the symptom cluster were examined using the longitudinal parallel process. Results: Pain and fatigue levels were highest during the post-induction phases of treatment and decreased slightly during maintenance therapy, while nausea scores were relatively stable. Even in the later phases of treatment, children continued to experience symptoms. CSF levels of the biomarkers increased during the post-induction phases of treatment. Early increases in the biomarkers were associated with more severe symptoms during the same period; patients who had increased biomarkers over time also experienced more severe symptoms over time. Conclusions: Findings reveal that children experienced symptoms throughout the course of leukemia treatment and support hypothesized longitudinal relationships of oxidative stress and inflammatory biomarkers with symptom severity. Activation of the biomarker pathways during treatment may explain underlying mechanisms of symptom experiences and identify which children are at risk for severe symptoms.

Original languageEnglish (US)
JournalBiological research for nursing
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Leukemia
Oxidative Stress
Biomarkers
F2-Isoprostanes
Therapeutics
Interleukin-8
Nausea
Fatigue
Cerebrospinal Fluid
Pain

Keywords

  • childhood leukemia
  • inflammatory biomarker
  • longitudinal parallel process
  • oxidative stress biomarker
  • symptom trajectory

ASJC Scopus subject areas

  • Research and Theory

Cite this

Influence of Inflammatory and Oxidative Stress Pathways on Longitudinal Symptom Experiences in Children With Leukemia. / Hockenberry, Marilyn J.; Pan, Wei; Scheurer, Michael E.; Hooke, Mary C.; Taylor, Olga; Koerner, Kari; Montgomery, David W; Whitman, Susan; Mitby, Pauline; Moore, Ida M.

In: Biological research for nursing, 01.01.2019.

Research output: Contribution to journalArticle

Hockenberry, Marilyn J. ; Pan, Wei ; Scheurer, Michael E. ; Hooke, Mary C. ; Taylor, Olga ; Koerner, Kari ; Montgomery, David W ; Whitman, Susan ; Mitby, Pauline ; Moore, Ida M. / Influence of Inflammatory and Oxidative Stress Pathways on Longitudinal Symptom Experiences in Children With Leukemia. In: Biological research for nursing. 2019.
@article{6c0e380053244ff0a4d3720770ed3632,
title = "Influence of Inflammatory and Oxidative Stress Pathways on Longitudinal Symptom Experiences in Children With Leukemia",
abstract = "Purpose: The purpose of this study was to explore the influence of oxidative stress (F2-isoprostanes) and inflammatory (interleukin [IL]-8) biomarkers on symptom trajectories during the first 18 months of childhood leukemia treatment. Method: A repeated-measures design was used to evaluate symptoms experienced by 218 children during treatment. A symptom cluster (fatigue, pain, and nausea) was explored over four time periods: initiation of post-induction therapy, 4 and 8 months into post-induction therapy, and the beginning of maintenance therapy (12 months postinduction). F2-isoprostanes and IL-8 were evaluated in cerebrospinal fluid (CSF) samples collected at baseline (diagnosis) and then at the four time periods. The longitudinal relationships of these biomarkers with the symptom cluster were examined using the longitudinal parallel process. Results: Pain and fatigue levels were highest during the post-induction phases of treatment and decreased slightly during maintenance therapy, while nausea scores were relatively stable. Even in the later phases of treatment, children continued to experience symptoms. CSF levels of the biomarkers increased during the post-induction phases of treatment. Early increases in the biomarkers were associated with more severe symptoms during the same period; patients who had increased biomarkers over time also experienced more severe symptoms over time. Conclusions: Findings reveal that children experienced symptoms throughout the course of leukemia treatment and support hypothesized longitudinal relationships of oxidative stress and inflammatory biomarkers with symptom severity. Activation of the biomarker pathways during treatment may explain underlying mechanisms of symptom experiences and identify which children are at risk for severe symptoms.",
keywords = "childhood leukemia, inflammatory biomarker, longitudinal parallel process, oxidative stress biomarker, symptom trajectory",
author = "Hockenberry, {Marilyn J.} and Wei Pan and Scheurer, {Michael E.} and Hooke, {Mary C.} and Olga Taylor and Kari Koerner and Montgomery, {David W} and Susan Whitman and Pauline Mitby and Moore, {Ida M}",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1099800419863160",
language = "English (US)",
journal = "Biological Research for Nursing",
issn = "1099-8004",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Influence of Inflammatory and Oxidative Stress Pathways on Longitudinal Symptom Experiences in Children With Leukemia

AU - Hockenberry, Marilyn J.

AU - Pan, Wei

AU - Scheurer, Michael E.

AU - Hooke, Mary C.

AU - Taylor, Olga

AU - Koerner, Kari

AU - Montgomery, David W

AU - Whitman, Susan

AU - Mitby, Pauline

AU - Moore, Ida M

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: The purpose of this study was to explore the influence of oxidative stress (F2-isoprostanes) and inflammatory (interleukin [IL]-8) biomarkers on symptom trajectories during the first 18 months of childhood leukemia treatment. Method: A repeated-measures design was used to evaluate symptoms experienced by 218 children during treatment. A symptom cluster (fatigue, pain, and nausea) was explored over four time periods: initiation of post-induction therapy, 4 and 8 months into post-induction therapy, and the beginning of maintenance therapy (12 months postinduction). F2-isoprostanes and IL-8 were evaluated in cerebrospinal fluid (CSF) samples collected at baseline (diagnosis) and then at the four time periods. The longitudinal relationships of these biomarkers with the symptom cluster were examined using the longitudinal parallel process. Results: Pain and fatigue levels were highest during the post-induction phases of treatment and decreased slightly during maintenance therapy, while nausea scores were relatively stable. Even in the later phases of treatment, children continued to experience symptoms. CSF levels of the biomarkers increased during the post-induction phases of treatment. Early increases in the biomarkers were associated with more severe symptoms during the same period; patients who had increased biomarkers over time also experienced more severe symptoms over time. Conclusions: Findings reveal that children experienced symptoms throughout the course of leukemia treatment and support hypothesized longitudinal relationships of oxidative stress and inflammatory biomarkers with symptom severity. Activation of the biomarker pathways during treatment may explain underlying mechanisms of symptom experiences and identify which children are at risk for severe symptoms.

AB - Purpose: The purpose of this study was to explore the influence of oxidative stress (F2-isoprostanes) and inflammatory (interleukin [IL]-8) biomarkers on symptom trajectories during the first 18 months of childhood leukemia treatment. Method: A repeated-measures design was used to evaluate symptoms experienced by 218 children during treatment. A symptom cluster (fatigue, pain, and nausea) was explored over four time periods: initiation of post-induction therapy, 4 and 8 months into post-induction therapy, and the beginning of maintenance therapy (12 months postinduction). F2-isoprostanes and IL-8 were evaluated in cerebrospinal fluid (CSF) samples collected at baseline (diagnosis) and then at the four time periods. The longitudinal relationships of these biomarkers with the symptom cluster were examined using the longitudinal parallel process. Results: Pain and fatigue levels were highest during the post-induction phases of treatment and decreased slightly during maintenance therapy, while nausea scores were relatively stable. Even in the later phases of treatment, children continued to experience symptoms. CSF levels of the biomarkers increased during the post-induction phases of treatment. Early increases in the biomarkers were associated with more severe symptoms during the same period; patients who had increased biomarkers over time also experienced more severe symptoms over time. Conclusions: Findings reveal that children experienced symptoms throughout the course of leukemia treatment and support hypothesized longitudinal relationships of oxidative stress and inflammatory biomarkers with symptom severity. Activation of the biomarker pathways during treatment may explain underlying mechanisms of symptom experiences and identify which children are at risk for severe symptoms.

KW - childhood leukemia

KW - inflammatory biomarker

KW - longitudinal parallel process

KW - oxidative stress biomarker

KW - symptom trajectory

UR - http://www.scopus.com/inward/record.url?scp=85070402216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070402216&partnerID=8YFLogxK

U2 - 10.1177/1099800419863160

DO - 10.1177/1099800419863160

M3 - Article

C2 - 31315444

AN - SCOPUS:85070402216

JO - Biological Research for Nursing

JF - Biological Research for Nursing

SN - 1099-8004

ER -